publication . Article . Other literature type . 2017

Hypermutation In Pancreatic Cancer

Humphris, Jeremy L.; Patch, Ann-Marie; Nones, Katia; Bailey, Peter J.; Johns, Amber L.; McKay, Skye; Chang, David K.; Miller, David K.; Pajic, Marina; Kassahn, Karin S.; ...
  • Published: 01 Jan 2017
  • Country: India
Pancreatic cancer is molecularly diverse, with few effective therapies. Increased mutation burden and defective DNA repair are associated with response to immune checkpoint inhibitors in several other cancer types. We interrogated 385 pancreatic cancer genomes to define hypermutation and its causes. Mutational signatures inferring defects in DNA repair were enriched in those with the highest mutation burdens. Mismatch repair deficiency was identified in 1% of tumors harboring different mechanisms of somatic inactivation of MLH1 and MSH2. Defining mutation load in individual pancreatic cancers and the optimal assay for patient selection may inform clinical trial ...
free text keywords: Gastroenterology, MLH1, DNA mismatch repair, Cancer research, DNA repair, Pancreatic cancer, medicine.disease, medicine, Somatic hypermutation, Mutation, medicine.disease_cause, MSH2, Cancer, business.industry, business
Funded by
NHMRC| Research Fellowship - Grant ID:427601
  • Funder: National Health and Medical Research Council (NHMRC) (NHMRC)
  • Project Code: 427601
  • Funding stream: NHMRC Research Fellowships
NHMRC| International Cancer Genome Consortium
  • Funder: National Health and Medical Research Council (NHMRC) (NHMRC)
  • Project Code: 631701
  • Funding stream: NHMRC Strategic Awards
Integrative Analysis of Gene Functions in Cellular and Animal Models of Pancreatic Cancer
  • Funder: European Commission (EC)
  • Project Code: 602783
  • Funding stream: FP7 | SP1 | HEALTH
NHMRC| Molecular markers of phenotype, therapeutic responsiveness and prognosis in human cancers.
  • Funder: National Health and Medical Research Council (NHMRC) (NHMRC)
  • Project Code: 535903
  • Funding stream: Programs
16 references, page 1 of 2

1. Vogelzang NJ, Benowitz SI, Adams S, et al. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology. J Clin Oncol 2012;30:88-109.

2. Bailey P, Chang DK, Nones K, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature 2016;531:47-52.

3. Biankin AV, Waddell N, Kassahn KS, et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 2012;491:399-405. [OpenAIRE]

4. Waddell N, Pajic M, Patch A-M, et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 2015;518:495-501. [OpenAIRE]

5. Le DT, Uram JN, Wang H, et al. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. New England Journal of Medicine 2015;372:2509-2520.

6. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012;487:330-7.

7. Goggins M, Offerhaus GJ, Hilgers W, et al. Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+. Am J Pathol 1998;152:1501-7. [OpenAIRE]

8. Alexandrov LB, Nik-Zainal S, Wedge DC, et al. Signatures of mutational processes in human cancer. Nature 2013;500:415-21.

9. Niu B, Ye K, Zhang Q, et al. MSIsensor: microsatellite instability detection using paired tumor-normal sequence data. Bioinformatics 2013.

10. Thompson BA, Spurdle AB, Plazzer J-P, et al. Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locusspecific database. Nat Genet 2014;46:107-115.

11. Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology 2010;138:2073-2087 e3.

12. Nones K, Waddell N, Wayte N, et al. Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis. Nat Commun 2014;5.

13. Grant RC, Selander I, Connor AA, et al. Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer. Gastroenterology 2015;148:556-64. [OpenAIRE]

14. Laghi L, Beghelli S, Spinelli A, et al. Irrelevance of microsatellite instability in the epidemiology of sporadic pancreatic ductal adenocarcinoma. PLoS One 2012;7:e46002. [OpenAIRE]

15. Nakata B, Wang YQ, Yashiro M, et al. Prognostic value of microsatellite instability in resectable pancreatic cancer. Clin Cancer Res 2002;8:2536-40.

16 references, page 1 of 2
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue